MEKK4 sequesters RIP2 to dictate NOD2 signal specificity

Area of Science:

• Immunology
• Molecular Biology
• Cell Signaling

Background:

• NOD2 is a key protein in the immune response to intracellular bacteria.
• The precise mechanisms by which NOD2 coordinates distinct signaling pathways (NFkappaB, JNK, p38) to regulate cytokine responses remain unclear.
• Dysregulated cytokine responses to gut bacteria are a hallmark of Crohn's disease.

Purpose of the Study:

• To elucidate the molecular mechanisms governing NOD2-mediated signaling pathway coordination.
• To investigate the role of MEKK4 in regulating NOD2 signaling.
• To explore the implications of these interactions in Crohn's disease pathogenesis.

Main Methods:

• Co-immunoprecipitation assays to detect protein-protein interactions.
• Stimulation of cells with NOD2 agonists (MDP) and other TLR agonists.
• Gene knockdown experiments (siRNA) in macrophages.
• Analysis of NFkappaB, JNK, and p38 pathway activation.

Main Results:

• MEKK4 binds to RIP2, sequestering it from the NOD2 signaling complex.
• NOD2 agonist (MDP) treatment dissociates the MEKK4:RIP2 complex, enabling NOD2:RIP2 interaction and NFkappaB activation.
• Crohn's disease-associated NOD2 polymorphisms impair RIP2 binding compared to MEKK4.
• MEKK4 knockdown in macrophages leads to increased NFkappaB activity and altered responses to TLR agonists.

Conclusions:

• MEKK4 acts as a negative regulator of NOD2 signaling by sequestering RIP2.
• Basal inhibition of the NOD2-NFkappaB pathway by MEKK4 is crucial for maintaining immune homeostasis.
• MEKK4's regulatory role and the impact of Crohn's disease-associated NOD2 variants on RIP2 binding highlight its potential significance in Crohn's disease pathogenesis.